Imperial College London

DrLucaMagnani

Faculty of MedicineDepartment of Surgery & Cancer

Senior Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 2808l.magnani CV

 
 
//

Location

 

140ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Magnani:2017:10.1038/ng0617-970b,
author = {Magnani, L and Frigè, G and Gadaleta, RM and Corleone, G and Fabris, S and Kempe, MH and Vershure, PJ and Barozzi, I and Vircillo, V and Hong, S-P and Perone, Y and Saini, M and Trumpp, A and Viale, G and Neri, A and Ali, S and Colleoni, MA and Pruneri, G and Minucci, S},
doi = {10.1038/ng0617-970b},
journal = {Nat Genet},
title = {Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.},
url = {http://dx.doi.org/10.1038/ng0617-970b},
volume = {49},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Magnani,L
AU - Frigè,G
AU - Gadaleta,RM
AU - Corleone,G
AU - Fabris,S
AU - Kempe,MH
AU - Vershure,PJ
AU - Barozzi,I
AU - Vircillo,V
AU - Hong,S-P
AU - Perone,Y
AU - Saini,M
AU - Trumpp,A
AU - Viale,G
AU - Neri,A
AU - Ali,S
AU - Colleoni,MA
AU - Pruneri,G
AU - Minucci,S
DO - 10.1038/ng0617-970b
PY - 2017///
TI - Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.
T2 - Nat Genet
UR - http://dx.doi.org/10.1038/ng0617-970b
UR - https://www.ncbi.nlm.nih.gov/pubmed/28546573
VL - 49
ER -